Echocardiography (cardiac ultrasound) is being used more often in the critical care setting for management of severe infection (septic shock). Early studies show echocardiography to be useful in these patients, but at this time, there are no good clinical trials to justify its use. Our study goals/objectives are as follows: 1. To conduct an unblinded, two-group randomized controlled clinical trial to compare an echocardiography-guided resuscitation protocol with an Early Goal Directed Therapy (EGDT) protocol in patients with severe sepsis or septic shock. 2. Demonstrate that a sepsis treatment protocol using transthoracic echocardiography and other non-invasive assessments of cardiac output will result in more rapid resolution of septic shock compared to invasive EGDT. 3. Demonstrate patients receiving the non-invasive echocardiography protocol will receive less administration of intravenous fluid.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
80
Patients will have their fluid resuscitation care guided by measurements obtained during an echo.
Patients will have their fluid resuscitation care guided by an EGDT protocol, which is currently used as standard of care.
Intermountain Medical Center
Murray, Utah, United States
Comparison of Serial organ failure assessment (SOFA) scores in both treatment arms
Time frame: up to 72 hours
Inpatient mortality in both treatment arms
Time frame: Up to ~7 days (Occurring during hospital stay).
Time to lactate clearance in both treatment arms
Time frame: Up to ~7 days (Occurring during ICU hospital stay).
Number of ICU-Free days
Time frame: 28 days
Daily and cumulative fluid balance in both treatment arms
Time frame: Up to ~7 days (Occurring during ICU hospital stay).
Number of ventilator-free days
Time frame: Up to ~7 days (Occurring during ICU hospital stay).
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.